AGCU ScienTech Incorporation was founded in late 2006 at Wuxi city.  It is located 80 miles west of Shanghai and at the center of the Yangzi Delta zone, which is the most developed region of China.  It’s committed itself to research and development, manufacturing, sales and technical service for genetic testing.  In just Six years, it has evolved as a leading company in DNA typing and nucleic acid detection in China.

The company has developed a series of nucleic acid detection products along with proprietary and breakthrough technologies, such as the first direct multiplex PCR amplification kit, fast and direct multiplex PCR amplification and the first 35-plex STR systems. Those technologies have been widely used in forensic DNA typing and related multiplex detecting fields. Some of its products have also been evaluated in a forensic lab in England and the results show our products performed as good as other branded ones.  The company has been awarded 20 patents with 5 pending and has more than ten projects were listed as national, provincial and ministerial, regional and municipal key projects including "State 863 projects", "State Science and Technology support projects", "The ministry of public Security key research projects".

AGCU has an excellent management and scientific research team; there are five staffs who have PhD or post doctor degrees and more than twenty staffs having master degrees. The company has R&D, manufacturing and office space which cover an area of over 40,000 square feet.  Two separate manufacturing facilities each has about 5000 square foot with cleanness level 100,000; Established "Wuxi DNA Typing scientific research experiment center" which has expanded its network throughout the nation.  With Yangtze River Delta as its business center, it has established a powerful DNA typing base and public DNA technical service platform with the most advanced technology, excellent scientific research and manufacturing capability and facilities.

Since 2011, AGCU has launched a series of world-leading forensic detection products. The company has also advanced into clinical genetic analysis and infection diseases control and other detection fields.